LEONHARDT VENTURES NEWS
Leonhardt’s Launchpads Expands into Playa Vista, LA Tech Capital
Leading innovation and startup accelerator focused on regenerative medtech and regenerative economy innovations is expanding into Playa Vista, California following Cedars Sinai, Yahoo, Imax, Google, YouTube, Facebook, USC Institute of Creative Technologies + USC...
Second Heart Assist, Inc. Raises $1.0M in Series A Financing
Capital to Fund Company Further Towards Early Feasibility Study of 1st Gen. Circulatory Assist Support Catheter Press Release – Salt Lake City, Utah Nov. 2, 2017 – Second Heart Assist, Inc. announced today that it raised $1.0 million in a Series A financing. The...
Leonhardt’s Launchpads Startup PancreaCell Makes It to Finals of American Diabetes Association National Pitch Contest
Press Release – Santa Monica, CA and Salt Lake City, Utah – Nov. 2, 2017 – PancreaCell a startup incubating within the Leonhardt’s Launchpads accelerators in California and Utah announced today it has made it to the final 10 of The American Diabetes Association’s 22nd...
EarCell Announces Revolutionary Bioelectric and Stem Cells Approach to Restore Hearing
Approach to regenerate inner ear sensory hair cells lays the groundwork for EarCell’s lead program for treating chronic noise-induced hearing loss Developed by a research team that has brought numerous breakthrough innovations from concept to market leadership...
Leonhardt and Genovese File Patent for Bioelectric Control of CXCL5 a Potential Protector Against Artery Occlusion and Cancer Tumor Growth
Salt Lake City, Utah and Los Angeles, CA – December 19th, 2017 (PRBUZZ) — Leonhardt’s Launchpads, an organ regeneration innovation/startup accelerator, focused on developing novel therapeutics for the treatment of organ degeneration today announced that it has filed a...
VascuStim Announces Launch of Diabetic Ulcer Clinical Research Program
Multi-site, prospective studies, and a patient registry, to commence in multiple countries with a total of 150 patients to be enrolled - titled the HEAL Registry Study Salt Lake City, Utah and Playa Vista, CA - November 27th, 2017-- VascuStim, an emerging leader in...
Brief quick elevator pitches for startups in 2017 portfolio class of Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. in order of most likely to exit soonest to latest…
WARNING: These elevator pitches are brief and concise by nature. By being so brief appropriate risks are not conveyed in these short statements. These elevator pitches reflect only the most positive optimistic personal opinions of the startup founders. Full risk...
PressureStim a Leonhardt Ventures Co. Announces Licensing of Patent Portfolio for Bioelectric Blood Pressure Management from Neuro Code Tech Holdings LLC Expanding Its Intellectual Property Estate.
Press Release – Santa Monica, California and Albuquerque, New Mexico, September 22nd, 2017 – PressureStim, an emerging leader in bioelectric blood pressure management announced today that the Company has entered into an option agreement that leads to an exclusive...
Leonhardt Ventures Announces Launch of DentaCell Accelerator
Playa Vista, CA and Salt Lake City, Utah (PRBUZZ), October 23rd, 2017 - Leonhardt Ventures is excited to announce a new accelerator program focused on transforming innovation in dentistry - The DentaCell Accelerator. The DentaCell Accelerator is committed to inviting...
Leonhardt Team Launches InStim Bioelectric Customized Inflammation Control
InStim is designed to read real time inflammatory and anti-inflammatory cytokines in body organs and then adjust real time up or down cytokine levels to get inflammation in balance and under control to promote optimal healing and long term organ health and function....